Edwyn
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $7,532 | $10,201 | $10,184 | $7,674 | $7,124 |
| Gross Profit | $2,085 | $4,098 | $3,620 | $1,682 | $1,313 |
| Operating Income | $1,710 | $3,643 | $3,080 | $1,186 | $685 |
| Net Income | $797 | $2,607 | $1,880 | $839 | $396 |
Over the five-year period, Weyerhaeuser’s financial performance exhibits notable volatility across its key income statement metrics. Revenue grew significantly from USD 7,532 million in 2020 to USD 10,201 million in 2021—a jump of nearly 35%—before experiencing declines in subsequent years, settling at USD 7,124 million in 2024. Gross profit similarly rose from USD 2,085 million in 2020 to a peak of USD 4,098 million in 2021, then fell to USD 1,313 million in 2024. Operating income followed this trend, peaking at USD 3,643 million in 2021 and then dropping to USD 685 million in 2024, while net income surged from USD 797 million in 2020 to USD 2,607 million in 2021 before declining sharply to USD 396 million in 2024. The over 20% year-over-year swing from 2020 to 2021 suggests a period of operational expansion and possibly favorable market conditions, followed by a steep contraction in later years. This dramatic turnaround in 2021 followed by consistent downturns suggests that while the company managed to capitalize on growth opportunities or cost improvements early on, subsequent market challenges and potential operational headwinds have eroded profitability. As one of the largest players in the forest products industry, which is closely tied to construction, housing, and environmental factors, Weyerhaeuser’s decline could be attributed to issues such as market saturation, rising raw material costs, or shifting demand dynamics. Overall, while the peak performance in 2021 illustrates the company’s capacity for robust earnings, the persistent declines in revenue, gross profit, operating income, and net income over the following years raise concerns about the sustainability of its financial health.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.